Novel hdac inhibitors for treatment of hemoglobinopathies
Ended Project Grant Awarded Last action
- Award ID
- R41HL136068
- Recipient
-
Cetya Therapeutics, Inc. UEI LJWQMH4FA7P3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $241,742
Award facts
- Assistance listing
- 93.839 Blood Diseases and Resources Research
- Completion date
- Place of performance
- Fort Collins, CO 80526, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $241,742 |
Quick answers
Who received award R41HL136068?
R41HL136068 was awarded to Cetya Therapeutics, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2017.
How much is award R41HL136068 worth?
$241,742 has been obligated on R41HL136068.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award